期刊文献+

^(99)Tc^m-annexinV在肺癌化疗评估中的应用 被引量:2

Application of ^(99)Tc^m-annexinV in Predicting the Therapeutic Effect of Chemical Agent on Lung Cancer
下载PDF
导出
摘要 目的制备放射性药物99Tcm-annexinV,评估其在早期预测肺癌化疗效果中的作用。方法通过毕赤酵母重组表达、硫酸铵沉淀和分子筛层析纯化得到annexinV,采用氯化亚锡还原法在annexinV的氨基端标记放射性核素99Tcm,经脱盐柱纯化获得标记产物。采用薄层层析测定99Tcm-annexinV的标记率和放射性化学纯度,外露磷脂酰丝氨酸的红细胞测定99Tcm-annexinV的生物活性。通过在615小鼠腋部皮下接种LA795细胞和组织插块法获得荷肺癌小鼠模型,经腹腔注射环磷酰胺治疗肺癌后6、12、24和48h测定99Tcm-annexinV在小鼠体内的分布情况。结果毕赤酵母工程菌株分泌表达annexinV,经硫酸铵分级沉淀和分子筛层析纯化后annexinV得以有效回收。室温下30min完成anne-xinV的99Tcm标记,标记率为50.2%。99Tcm-annexinV放射性化学纯度为93.9%,其生物活性保存良好。生物分布实验表明,99Tcm-annexinV通过肾脏排泄。615荷肺癌小鼠模型经过环磷酰胺化疗后48h,99Tcm-annexinV在肿瘤组织的摄取达到最高,肿瘤/肌肉放射性摄取率之比为6.34,肿瘤/血液放射性摄取率之比为4.09。结论制备了毕赤酵母来源的99Tcm-annexinV,有可能应用于早期预测肺癌化疗效果。 Objective To prepare 99Tcm-annexinV and evaluate its application in the early prediction of therapeutic effect of chemical agent on tung cancer. Methods Annexin V was obtained by recombinant pichia pastoris expression, ammonium sulfate precipitation, and size-exclusion chromatography. The purified protein was labeled with 99Tcm at the N-terminal site by stannous chloride reduction and purified by desahing. The labeling yield and radiochemical purity of 99Tcm-annexinV were determined by instant thin-layer chromato- graphy. The biological activity of 99Tcm-annexinV was tested by phosphatidylserine-exposed erythrocytes bound radioactivity counting. The lung cancer mice models were established by inoculating LA795 cells to right flank of 615 mice subcutaneously and tumor tissue transplantation. The biodistribution of 99Tcm-annexinin V in lung cancer mice models were investigated at 6, 12, 24, and 48 h after eyclophosphamide administration. Results The annexin V was secreted from pichia pastoris and purified by ammonium sulfate precipitation and size-exclusion chromatography with high yield. The annexin V could be labeled at room temperature with 50.2% radioactivity yield. The radiochemical purity of 99Tcm-annexinVreached up to 93.9% with intact biological activity. The biodistribution analysis demonstrated that 99Tcm-annexinV was excreted from kidney. The uptake of 99Tcm-annexinV at tumor reached maximum 48 h after cyclophosphamide administration while tumor to muscle ratio was 6.34 and tumor to blood ratio was 4.09. Conclusions 99Tcm-annexinV derived from pichia pastoris was successfully prepared. It is useful in predicting the therapeutic effect of chemical agent on lung cancer.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2008年第5期595-598,F0003,共5页 Acta Academiae Medicinae Sinicae
基金 霍英东肺癌专项基金~~
关键词 99Tcm-annexinV 肺癌 环磷酰胺 LA795 生物分布 99 m Tc -annexm V lung cancer cyclophosphamide LA795 biodistribution
  • 相关文献

参考文献5

  • 1Gilligan D, Nicolson M, Smith I, et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 muhicentre randomised trial and update of systematic review [ J ]. Lancet, 2007, 369 (9577) : 1929-1937.
  • 2Kartachova M, van Zandwijk N, Burgers S, et al. Prognostic significance of ^99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer [ J ]. J Clin Oncol, 2007, 25(18):2534-2539.
  • 3蔡炯,李方,张迎强,郑连芳,蒲圻.突变型人膜联蛋白V的重组表达[J].中国医学科学院学报,2006,28(4):549-552. 被引量:5
  • 4Sambrook J,Russell D W.黄培堂,王嘉玺,朱厚咄,译.分子克隆实验指南[M].3版.北京:科学出版社,2002,385-701.
  • 5邓淑华,石艳华,王宏梅.小鼠肺腺癌LA795细胞系移植特性的初步观察[J].河北医学,2000,6(1):30-32. 被引量:3

二级参考文献29

  • 1Wang F,He XW,Yan HL,et al.Non-fusion expression in escherichia coli:single-step purification of recombinant human annexin A5 for detection of apoptosis.Protein Expr Purif,2006,45(1):80-87.
  • 2Verbeke K,Kieffer D,Vanderheyden JL,et al.Optimization of the preparation of 99mTc-labeled hynic-derivatized annexin V for human use.Nucl Med Biol,2003,30(7):771-778.
  • 3Vermeersch H,Loose D,Lahorte C,et al.99mTc-HYNIC annexin-V imaging of primary head and neck carcinoma.Nucl Med Commun,2004,25(3):259-263.
  • 4Tait JF,Smith C,Blankenberg FG.Structural requirements for in vivo detection of cell death with 99mTc-annexin V.J Nucl Med,2005,46(5):807-815.
  • 5Mclaughlin R,Kelly C J,Kay E,et al.The role of apoptotic cell death in cardiovascular disease.Ir J Med Sci,2001,170(2):132-140.
  • 6Mattson MP,Duan W,Pedersen WA,et al.Neurodegenerative disorders and ischemic brain diseases.Apoptosis,2001,6(12):69-81.
  • 7Kerr JF,Winterford CM,Harmon BV.Apoptosisi:its significance in cancer and cancer therapy.Cancer,1994,73 (8):2013-2026.
  • 8Hofstra L,Liem IH,Dumont EA,et al.Visualisation of apoptosis in vivo in patients with an acute myocardial infarcation.Lancet,2000,356:209-212.
  • 9Boersma HH,Liem IH,Kemerink GJ,et al.Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin AS.Br J Radiol,2003,76:553-560.
  • 10Lahorte CM,Vanderheyden JL,Steinmetz N,et al.Apoptosisdetecting radioligands:current state of the art and future perspectives.Eur J Nucl Med Mol Imaging,2004,31 (6):887-919.

共引文献16

同被引文献29

  • 1蔡炯,李方,郑连芳,张迎强,蒲圻,王世真.人膜联蛋白V的重组表达与细胞凋亡显像[J].基础医学与临床,2006,26(8):913-914. 被引量:2
  • 2蔡炯,李方,张迎强,郑连芳,蒲圻.突变型人膜联蛋白V的重组表达[J].中国医学科学院学报,2006,28(4):549-552. 被引量:5
  • 3张迎强,蔡炯,李方,郑连芳,邱飞蝉,刘丽琴.荷肉瘤小鼠肿瘤细胞凋亡显像实验研究[J].医学研究杂志,2007,36(2):30-33. 被引量:4
  • 4Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy [ J ]. Cell, 2002, 108(2): 153-164.
  • 5Laufer EM, Winkens HM, Corsten MF, et al. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5 [ J ]. Q J Nucl Med Mol Imaging, 2009, 53 ( 1 ) : 26 - 34.
  • 6Blankenberg FG. Monitoring of treatment-induced apoptosis in oncology with PET and SPECT [ J ]. Curr Pharm Des, 2008, 14(28) : 2974-2982.
  • 7Kurihara H, Yang D J, Cristofanilli M, et al. Imaging and dosimetry of ^99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors [ J ]. Appl Radiat Isot, 2008, 66(9) : 1175 -1152.
  • 8Hoebers FJ, Kartachova M, de Bois J, et al. ^99mTc Hynic- rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemora- diotherapy[J]. Eur J Nucl Med Mol Imaging, 2008, 35 (3) : 509 -518.
  • 9Kietselaer BL, Reutelingsperger CP, Boersma HH, et al. Noninvasive detection of programmed cell loss with ^99m Tc- labeled annexin A5 in heart failure [ J ]. J Nucl Med, 2007, 48(4): 562-567.
  • 10Tait JF, Smith C, Levashova Z, et al. Improved detection of cell death in vivo with annexin V radiolabeled by sitespecific methods[J]. J Nucl Med, 2006, 47(9) : 1546 - 1553.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部